Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
27.8M
-
Shares change
-
+948K
-
Total reported value, excl. options
-
$626M
-
Value change
-
+$21.5M
-
Number of buys
-
33
-
Number of sells
-
-9
-
Price
-
$22.65
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q3 2020
52 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q3 2020.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.8M shares
of 61.7M outstanding shares and own 44.98% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.84M shares), FMR LLC (5.32M shares), Redmile Group, LLC (3.39M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.84M shares), CHI Advisors LLC (2.35M shares), TRV GP IV, LLC (2.13M shares), CITADEL ADVISORS LLC (1.23M shares), FARALLON CAPITAL MANAGEMENT LLC (764K shares), Cormorant Asset Management, LP (611K shares), and HARVARD MANAGEMENT CO INC (562K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.